Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 79.59%-1.26M | 288.58%2.71M | 20.27%-1.38M | 57.62%-876K | -79.02%-1.72M | -62.16%-6.19M | 17.80%-1.44M | -518.36%-1.73M | -78.50%-2.07M | 27.86%-958K |
| Net income from continuing operations | 82.68%-1.69M | 55.84%-1.82M | 45.70%-1.43M | 231.02%2.41M | 26.04%-852K | -100.74%-9.74M | -168.82%-4.12M | -181.58%-2.63M | -79.79%-1.84M | 15.48%-1.15M |
| Operating gains losses | ---3.59M | --66K | --10K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 294.64%221K | 1,073.33%176K | 7.14%15K | 41.67%17K | -13.33%13K | -11.11%56K | -16.67%15K | -12.50%14K | -40.00%12K | 66.67%15K |
| Asset impairment expenditure | -1.14%1.21M | 1.96%1.25M | --0 | -143.33%-13K | 16.67%-25K | --1.22M | --1.22M | --0 | --30K | ---30K |
| Remuneration paid in stock | --0 | 108.70%48K | -116.67%-2K | --0 | -475.00%-46K | -222.00%-183K | -79.09%23K | 140.00%12K | -800.00%-210K | -260.00%-8K |
| Remuneration paid in stock | -12.15%947K | 121.74%204K | 24.25%456K | -57.48%196K | -42.41%91K | 55.33%1.08M | 6.98%92K | 439.71%367K | 68.25%461K | -40.60%158K |
| Other non cashItems | --77K | --2K | ---37K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 13.07%1.56M | 109.08%2.79M | -178.22%-395K | 112.14%63K | -1,618.64%-896K | 975.78%1.38M | 411.21%1.33M | -59.89%505K | -13.32%-519K | 124.08%59K |
| -Change in receivables | -7,059.09%-1.58M | -262.93%-756K | -100.68%-14K | 144.98%623K | -23.85%-1.43M | -102.43%-22K | -26.23%464K | 211.38%2.05M | -384.27%-1.39M | -1,101.04%-1.15M |
| -Change in inventory | 80.10%-487K | -565.63%-639K | 102.00%7K | 159.15%488K | 70.83%-343K | -1,132.49%-2.45M | -136.36%-96K | -199.15%-350K | -209.42%-825K | -77.11%-1.18M |
| -Change in prepaid assets | -162.75%-536K | 288.03%1.1M | -496.57%-924K | 39.48%-423K | -1,222.73%-291K | -3,300.00%-204K | 353.57%284K | -17.38%233K | -80.62%-699K | -110.43%-22K |
| -Change in payables and accrued expense | 12.84%4.57M | 294.24%3.49M | 135.50%536K | -126.75%-612K | -51.68%1.15M | 585.03%4.05M | 185.60%886K | -447.13%-1.51M | 524.49%2.29M | 684.87%2.39M |
| -Change in other current assets | ---- | ---- | --0 | -112.75%-13K | -45.83%13K | 179.89%139K | 61.49%-67K | --80K | --102K | --24K |
| -Change in other working capital | ---415K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 79.59%-1.26M | 288.58%2.71M | 20.27%-1.38M | 57.62%-876K | -79.02%-1.72M | -62.16%-6.19M | 17.80%-1.44M | -518.36%-1.73M | -78.50%-2.07M | 27.86%-958K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1,733.33%441K | -572K | 1,551.85%392K | 63.01%-27K | 0 | 43.75%-27K | 0 | 0 | ||
| Net PPE purchase and sale | -1,544.44%-444K | ---454K | 122.22%6K | ---- | ---- | 63.01%-27K | --0 | 43.75%-27K | --0 | --0 |
| Net business purchase and sale | --885K | ---118K | --386K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 1,733.33%441K | ---572K | 1,551.85%392K | ---- | ---- | 63.01%-27K | --0 | 43.75%-27K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -31.90%2.5M | 222.52%1.2M | -82.41%562K | -207.56%-185K | 1,321.33%916K | 1,589.84%3.67M | 4.48%373K | 1,738.46%3.2M | 184.31%172K | 63.24%-75K |
| Net issuance payments of debt | 833.68%2.72M | 320.96%1.23M | 344.09%620K | -111.80%-44K | 869.75%916K | --291K | -52.45%291K | 58.50%-254K | 82.84%373K | 41.67%-119K |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --3.6M | ---60K | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | 800.00%81K | --0 | --0 | --37K | --44K |
| Net other financing activities | 28.25%-221K | -115.49%-22K | 72.64%-58K | ---- | ---- | -20.78%-308K | --142K | ---212K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -31.90%2.5M | 222.52%1.2M | -82.41%562K | -207.56%-185K | 1,321.33%916K | 1,589.84%3.67M | 4.48%373K | 1,738.46%3.2M | 184.31%172K | 63.24%-75K |
| Net cash flow | ||||||||||
| Beginning cash position | -60.36%1.53M | -92.08%199K | -49.77%650K | -74.00%735K | -60.36%1.53M | -51.49%3.87M | -51.87%2.51M | -74.51%1.29M | -56.04%2.83M | -51.49%3.87M |
| Current changes in cash | 188.78%2M | 403.68%3.38M | -135.12%-427K | 88.53%-152K | 22.65%-799K | 45.51%-2.26M | 19.93%-1.11M | 611.11%1.22M | 3.99%-1.33M | 32.88%-1.03M |
| Effect of exchange rate changes | 181.01%64K | 151.28%20K | -284.62%-24K | 245.65%67K | 114.29%1K | -332.35%-79K | -208.33%-39K | 150.00%13K | -284.00%-46K | -600.00%-7K |
| Cash adjustments other than cash changes | --0 | --0 | --0 | ---- | ---- | ---258K | ---86K | ---10K | ---- | ---- |
| End cash Position | 182.27%3.6M | 182.27%3.6M | -92.08%199K | -49.77%650K | -74.00%735K | -67.03%1.28M | -67.03%1.28M | -51.87%2.51M | -74.51%1.29M | -56.04%2.83M |
| Free cash from | 72.38%-1.72M | 256.96%2.25M | 21.49%-1.38M | 57.62%-876K | -79.02%-1.72M | -59.82%-6.22M | 17.80%-1.44M | -580.60%-1.76M | -75.77%-2.07M | 28.24%-958K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.